1.
Mockenhaupt M, Grosber M, Norganer J. Daclizumab: a novel therapeutic option in severe bullous pemphigoid. Acta Derm Venereol [Internet]. 2005 Jan. 26 [cited 2025 Feb. 22];85(1):65-6. Available from: https://medicaljournalssweden.se/actadv/article/view/13494